More on Premetrologic Variation
To the Editor: Generally, clinicians and laboratorians consider that premetrologic variation is negligible if all premetrologic sources of variation are standardized (1 ) , but it has been demonstrated that in many instances this is not so (2) (3) (4) . The aim of this study is to quantify the premetrologic variation associated with 33 biochemical quantities frequently measured in clinical laboratories.
All premetrologic procedures (sampling, transport, centrifugation, handling, and distribution of the samples) were done according to the working instructions of our laboratory. We recruited 38 healthy volunteers. Each individual had two immediately consecutive withdrawals, one from each arm at random, done by two different phlebotomists; the pair of phlebotomists was different for each individual. The samples were obtained from the antecubital vein, using evacuated tubes without additives but with a gel barrier as serum separator (Vacutainer ® ; product no. 368510; Becton Dickinson). After the sampling process, the tubes were sent to the premetrologic area of our laboratory, where the samples were held for a time before being centrifuged. The tubes of blood obtained by the first phlebotomist were centrifuged under standardized conditions (1200g for 10 min at 25°C) 30 min after the withdrawal, whereas the tubes obtained by the second phlebotomist were centrifuged under the same conditions as the others but 90 min after the withdrawal. After centrifugation, the tubes were distributed to the appropriate analyzers. A pair of samples from each individual was measured, and one of each pair, randomly chosen, was measured again.
The For each quantity, the general metrologic variance was calculated as:
Where s G 2 is the general metrologic variance (within-run metrologic variance plus premetrologic variance); x and y are the results obtained for different samples from the same individual; and n is the number of individuals.
For each quantity, the metrologic within-run variance was calculated as:
Where s Mw 2 is the metrologic withinrun variance; z and zЈ are the replicate results, and n is the number of individuals.
Finally, the premetrologic variance was obtained by subtracting s Mw 2 from s G 2 , and the corresponding CV was calculated using the mean of all measurements done for each quantity.
The CVs corresponding to premetrologic variation different from zero are shown in Table 1 ; CVs corresponding to the day-to-day imprecision at physiologic concentrations observed during the study are also included for comparative purposes. According to these results, one third of the serum components included in the study had premetrologic CVs greater than our day-to-day imprecision (values in bold italics in Table 1) , and 37% had premetrologic CVs not negligible but lower than our day-today imprecision. The premetrologic CVs were negligible for the remaining 30% (apolipoproteins B, CA 19-9 antigen, luteinizing hormone, magnesium, pancreatic ␣-amylase, prostate-specific antigen, rheumatoid factors, testosterone, triacylglycerol lipase, and serum osmolality). We think, however, that when the waiting time for samples before centrifugation is extended to 3 or 4 h, as sometimes occurs in a routine setting, the premetrologic CVs will be higher than the observed ones.
The results in this study, as in two previous studies (3, 4 ) , indicate that premetrologic variation should generally not be ignored. The errors in the premetrologic phase are originally systematic; on a day-to-day basis, however, these errors could be considered together as random phenomena, and the corresponding variance should be taken into account when estimating the uncertainty of 1 and HbA 1c , respectively; in large epidemiologic studies, however, storage of whole blood would be more practical. A recent report stated that whole blood was stable at Ϫ70°C for 1 year, but no evidence was cited (3 ) . The aim of this study was therefore to test the hypothesis that whole blood is stable at Ϫ70°C for 1 year for HbA 1c measurement.
Venous blood was collected from 99 children (age, 10 years) without diabetes over a 3-week period in the Avon Longitudinal Study of Parents and Children (ALSPAC; www. alspac.bris.ac.uk). The anticoagulant used was lithium heparin. Available blood was limited, and 10 identical 5-L aliquots of whole blood in 1 mL of 40H-HPLC-hemolysant (specific to our assay; contains phosphate buffer, sodium azide, and surfactant) were prepared for each child. One aliquot was assayed fresh for HbA 1c (baseline values), and the remainder were frozen at Ϫ70°C. Whole blood was also stored undiluted in hemolysant. Stored aliquots were assayed for HbA 1c after periods of 9, 16, 25, 31, 45, and 56 weeks. After 56 weeks, the stored undiluted whole blood from each child was also assayed. Fig 1) . Differences between fresh and frozen measurements were unrelated to HbA 1c value; mean differences ranged from Ϫ0.001% to 0.17% HbA 1c ; repeatability coefficients ranged from 0.23% to 0.28%; and limits of agreement were between Ϫ0.2% and 0.4%. Variability could largely be explained by assay Fig. 1 . Agreement between HbA 1c measured in fresh whole blood (baseline) and in identical aliquots of whole blood stored at Ϫ70°C for 56 weeks, without previous dilution in 40H-HPLC-hemolysant (n ϭ 99).
Baseline blood collection took place over a 3-week period, and baseline HbA 1c measurements have been adjusted for time. RC, repeatability coefficient.
